Cargando…
Measurement of HbA1c in multicentre diabetes trials – should blood samples be tested locally or sent to a central laboratory: an agreement analysis
BACKGROUND: Glycated haemoglobin (HbA1c) is an important outcome measure in diabetes clinical trials. For multicentre designs, HbA1c can be measured locally at participating centres or by sending blood samples to a central laboratory. This study analyses the agreement between local and central measu...
Autores principales: | Arch, Barbara N., Blair, Joanne, McKay, Andrew, Gregory, John W., Newland, Paul, Gamble, Carrol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078896/ https://www.ncbi.nlm.nih.gov/pubmed/27776543 http://dx.doi.org/10.1186/s13063-016-1640-6 |
Ejemplares similares
-
Erratum to: Measurement of HbA1c in multicentre diabetes trials – should blood samples be tested locally or sent to a central laboratory: an agreement analysis
por: Arch, Barbara N., et al.
Publicado: (2017) -
Response to letter to editor: ‘Comment on Arch et al., Trials. 2016;17:517’
por: Arch, B. N., et al.
Publicado: (2017) -
Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
por: Jones, Angus G., et al.
Publicado: (2016) -
Level of agreement of point-of-care and laboratory HbA1c measurements in the preoperative outpatient clinic in non-diabetic patients who are overweight or obese
por: van Raalten, Floris, et al.
Publicado: (2019) -
Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)